| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000010793 |
| Receipt No. | R000012632 |
| Scientific Title | Prospective cohort study of patients with CKD and development of medical system for CKD and CVD |
| Date of disclosure of the study information | 2013/05/24 |
| Last modified on | 2022/11/29 (Ver. 15) |
| Basic information | ||
| Public title | Prospective cohort study of patients with CKD and development of medical system for CKD and CVD | |
| Acronym | Kakusyo CKD/CVD cohort (3C) study | |
| Scientific Title | Prospective cohort study of patients with CKD and development of medical system for CKD and CVD | |
| Scientific Title:Acronym | Kakusyo CKD/CVD cohort (3C) study | |
| Region |
|
|
| Condition | ||
| Condition | Chronic Kidney Disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of the current study is to prospective follow patients with CKD including high risk patients for CVD in associated hospitals of Okayama University Hospital, and to evaluate risk factors and predictive factors for progression of CKD, ESRD, CVD onset and death. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 1. Composite renal endpoint (ESRD, 50% reduction of eGFR and death)
2. Onset of cardiovascular events |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with chronic kidney disease | |||
| Key exclusion criteria | Patients on dialysis and patients receiving renal transplantation | |||
| Target sample size | 1200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences | ||||||
| Division name | Dept. of CKD and CVD | ||||||
| Zip code | 7008558 | ||||||
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama city | ||||||
| TEL | 086-235-7235 | ||||||
| hauchida@okayama-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences | ||||||
| Division name | Dept. of CKD and CVD | ||||||
| Zip code | 7008558 | ||||||
| Address | 2-5-1,Shikata-cho, Kita-ku, Okayama city | ||||||
| TEL | 086-235-7235 | ||||||
| Homepage URL | |||||||
| hauchida@okayama-u.ac.jp | |||||||
| Sponsor | |
| Institute | Okayama University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital |
| Address | 2-5-1 Shikata-cho, Kita-ku, Okayama city |
| Tel | 086-235-6503 |
| mae6605@adm.okayama-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岡山大学病院、岡山大学病院関連施設 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 200 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | To delay in writing manuscript | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | All data were fixed, and writing manuscript is going |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012632 |